Vacuum-assisted Closure Versus Conventional Dressings in Infected Lower-limb Wounds
Comparison of Vacuum-assisted Closure Versus Conventional Wound Dressings in the Management of Infected Lower-limb Wounds
1 other identifier
interventional
90
1 country
1
Brief Summary
Wound healing is a complex and dynamic process that includes an immediate sequence of cell migration leading to repair and closure. Delayed wound healing or non-healing of ulcers is a significant health problem, particularly in older adults. Vacuum assisted closure (VAC) is a relatively new technology with applications in a variety of difficult to manage acute and chronic wounds. Literature showed that the outcomes of VAC is a better than other method. Therefore, this study has been planned. This Randomized controlled trial will be done at Department of General Surgery, Dr Faisal Masood Teaching Hospital, Sargodha for 12 months.Sample size of 90 cases; 45 in each groups will be included through Non-probability consecutive sampling and will be randomly divided into 2 equal groups. In group A, VAC will be applied to wound. In group B, conventional dressing will be applied on wound. Wound size after one week will be assessed. If wound will heal completely, then duration for complete healing will be noted. Success will also be noted. All the data will be recorded in proforma.All the data will be analyzed with SPSS version 25. Both groups will be compared by using independent samples t-test for duration of healing, and wound size after a week and chi-square test for success. P-value ≤ 0.05 will be considered as significant. Conclusion and recommendations will be made to obtain better results with high success rate, which will lead to better quality of life and early discharge of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2026
CompletedFirst Submitted
Initial submission to the registry
August 26, 2026
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedSeptember 3, 2026
September 1, 2026
1.1 years
August 26, 2026
September 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in wound size
7 days after initiation of treatment
Secondary Outcomes (1)
Treatment success rate
Within two weeks of treatment
Other Outcomes (1)
Duration of treatment/complete healing
Treatment success rate within 2 weeks
Study Arms (2)
VAC Therapy
EXPERIMENTALParticipants will receive vacuum-assisted closure (VAC) therapy for management of infected lower-limb wounds.
Conventional Dressing
ACTIVE COMPARATORParticipants will receive conventional wound dressing for management of infected lower-limb wounds.
Interventions
Application of vacuum-assisted closure (VAC) therapy to infected lower-limb wounds using negative pressure wound therapy, with appropriate wound preparation and dressing changes according to the study protocol."
Routine conventional dressing of infected lower-limb wounds using standard wound-care techniques and appropriate dressing materials, with dressing changes performed according to the study protocol."
Eligibility Criteria
You may qualify if:
- Adult population aged 18 - 40 years.
- Gender;both male and female.
- Patients having infected wound of lower limb (as per operational definition).
You may not qualify if:
- \> Recurrent cases (on medical record)
- Patients with metabolic diseases, taking steroids, with peripheral vascular disease, cancer.
- Patients with complications such as septic shock, diabetic ketoacidosis, or kidney injuries (on medical record)
- Patients whose vitals were unstable (on clinical examination and medical record)
- Patients with any evidence of underlying bone osteomyelitis and malignancy (on medical record).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Faisal Masood teaching Hospital Sargodha
Sargodha, Punjab Province, 40100, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2026
First Posted
August 31, 2026
Study Start
July 16, 2025
Primary Completion
August 14, 2026
Study Completion
August 24, 2026
Last Updated
September 3, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share